GB202012727D0 - Modified host cells and uses thereof - Google Patents

Modified host cells and uses thereof

Info

Publication number
GB202012727D0
GB202012727D0 GBGB2012727.0A GB202012727A GB202012727D0 GB 202012727 D0 GB202012727 D0 GB 202012727D0 GB 202012727 A GB202012727 A GB 202012727A GB 202012727 D0 GB202012727 D0 GB 202012727D0
Authority
GB
United Kingdom
Prior art keywords
host cells
modified host
modified
cells
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2012727.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB2012727.0A priority Critical patent/GB202012727D0/en
Publication of GB202012727D0 publication Critical patent/GB202012727D0/en
Ceased legal-status Critical Current

Links

GBGB2012727.0A 2020-08-14 2020-08-14 Modified host cells and uses thereof Ceased GB202012727D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2012727.0A GB202012727D0 (en) 2020-08-14 2020-08-14 Modified host cells and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2012727.0A GB202012727D0 (en) 2020-08-14 2020-08-14 Modified host cells and uses thereof

Publications (1)

Publication Number Publication Date
GB202012727D0 true GB202012727D0 (en) 2020-09-30

Family

ID=72615332

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2012727.0A Ceased GB202012727D0 (en) 2020-08-14 2020-08-14 Modified host cells and uses thereof

Country Status (1)

Country Link
GB (1) GB202012727D0 (en)

Similar Documents

Publication Publication Date Title
EP3586852B8 (en) Modified cell expansion and uses thereof
EP3680338A4 (en) Genetically engineered t cell and application thereof
IL291484A (en) Multi-targeting effector cells and use thereof
EP3908294A4 (en) Modified cell expansion and uses thereof
EP3668972B8 (en) Engineered dnase enzymes and use in therapy
EP3686275A4 (en) Gene editing t cell and use thereof
EP3380117A4 (en) Genetically modified cells and uses thereof
EP4089174A4 (en) Engineered immune cell and use thereof
EP3810190A4 (en) Engineered cells and uses thereof
EP3964238A4 (en) Bcma-targeting engineered immune cell and use thereof
EP3959307A4 (en) Engineered cells and uses thereof
EP3822345A4 (en) Genetically engineered cell and application thereof
EP4165049A4 (en) Isotryptamine psychoplastogens and uses thereof
IL286873A (en) Cell culture systems and uses thereof
EP3810756A4 (en) Modified t cells and uses thereof
EP3788151A4 (en) Engineered cells with modified host cell protein profiles
EP4121031A4 (en) 3-diarylmethylenes and uses thereof
EP3712268A4 (en) Transformed human cell and use thereof
EP4036222A4 (en) Modified immune cell and use thereof
EP4117682A4 (en) Modified nucleotides and uses thereof
GB202012727D0 (en) Modified host cells and uses thereof
GB201910402D0 (en) Modified host cells and uses thereof
EP4200023A4 (en) Hla-f-modified cells and methods
EP3732290A4 (en) Host cells with enhanced protein expression efficiency and uses thereof
EP4028024A4 (en) Engineered cells and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)